📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 13:54
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
Pentokey Organy India Ltd Approves Q1 FY27 Results; TTM Revenue at Rs 2 Cr
Pentokey Organy India Ltd approved its standalone unaudited financial results for the quarter ended June 30, 2026, in a board meeting on August 13, 2026. The company is a micro-cap entity with a market capitalization of Rs 21 Cr and a TTM revenue of only Rs 2 Cr. Recent financial performance has been under significant pressure, with the company reporting negative operating margins of -10.5% and volatile revenue figures in previous quarters. While the specific P&L numbers for Q1 FY27 were not detailed in the announcement extract, the company maintains a zero-debt balance sheet.
Confidence: MEDIUM
What changedThe company has completed its mandatory quarterly financial reporting for the period ending June 30, 2026.
Why it mattersFor a micro-cap company with inconsistent revenue and low liquidity, these filings are the primary source of information regarding business continuity and potential recovery.
Market Capitalization: Rs 21 CrTTM Revenue: Rs 2 CrTTM Operating Margin: -10.5%Promoter Holding: 73.03%Q1 FY27 Revenue: not disclosed
📅 Short termThe stock is likely to remain neutral as the market digests the full numerical results once they are fully accessible beyond the board outcome summary.
📈 Long termLimited structural significance unless the company can scale its revenue back to the Rs 5 Cr+ per quarter levels seen in early 2025.
⚠ Risk flags
- Extremely small revenue base
- History of negative operating margins
- Micro-cap liquidity and volatility risks
Key Highlights
Board meeting held on August 13, 2026, to approve Q1 FY27 unaudited results.
Company operates at a very small scale with TTM revenue of just Rs 2 Cr.
Promoter holding remains stable and high at 73.03% as of the last reporting cycle.
The company maintains a zero-debt status (D/E of 0.00) with a net worth of Rs 10 Cr.
Market capitalization stands at approximately Rs 21 Cr as of the announcement date.
👀 What to Watch
Investors should examine the full financial statement to see if the revenue has stabilized after reporting negative figures in the previous two quarters (Mar 2026 and Dec 2025).
Pentokey Organy Approves Q1 FY27 Results; TTM Revenue Stands at Rs 2 Cr
Pentokey Organy (India) Ltd approved its unaudited financial results for the quarter ended June 30, 2026. The company is a micro-cap in the commodity chemicals sector with a market capitalization of only Rs 21 Cr. Recent performance has been under significant pressure, with TTM revenue at just Rs 2 Cr and negative revenue reported in the preceding two quarters (Mar 2026 and Dec 2025). The board meeting was brief, lasting 40 minutes, and the statutory auditors issued a limited review report with no major qualifications mentioned in the summary.
Confidence: MEDIUM
What changedThe company has formally approved and released its financial performance data for the first quarter of the 2026-27 fiscal year.
Why it mattersFor a micro-cap with volatile earnings and a high P/E of 106.5, these results are critical to determine if the business is stabilizing or continuing to face operational contraction.
Market Cap: Rs 21 CrTTM Revenue: Rs 2 CrPromoter Holding: 73.03%P/E Ratio: 106.5Meeting Duration: 40 minutes
📅 Short termThe stock may remain range-bound given the small market cap and the need for the market to digest the specific Q1 performance numbers.
📈 Long termLimited structural significance unless the company demonstrates a consistent ability to scale revenue beyond the current TTM level of Rs 2 Cr.
⚠ Risk flags
- Extremely low revenue base
- High valuation (P/E > 100)
- History of negative quarterly revenue
Key Highlights
Board approved unaudited financial results for the quarter ended June 30, 2026
The board meeting commenced at 12:30 PM and concluded at 01:10 PM
Company maintains a high promoter holding of 73.03% as per latest context
TTM revenue is currently low at Rs 2 Cr compared to a market cap of Rs 21 Cr
Statutory auditors Verma Mehta & Associates completed a limited review of the results
👀 What to Watch
Investors should examine the full P&L statement to see if the company has returned to positive revenue after reporting negative figures in the previous two quarters.
